Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toni Cathomen

Showing results (81-90 of 172) with videos related to

Pageof 18
Sort By:
Nature Methods|August 26, 2014
Adenoviral vector DNA for accurate genome editing with engineered nucleasesMaarten Holkers, Ignazio Maggio, Sara F D Henriques, et al.
Peerj|December 7, 2020
HIV-1 promoter is gradually silenced when integrated into <i>BACH2</i> in Jurkat T-cellsAnne Inderbitzin, Yik Lim Kok, Lisa Jörimann, et al.
Cancers|June 26, 2020
An Anti-PSMA Immunotoxin Reduces Mcl-1 and Bcl2A1 and Specifically Induces in Combination with the BAD-Like BH3 Mimetic ABT-737 Apoptosis in Prostate Cancer CellsAnie P Masilamani, Viviane Dettmer-Monaco, Gianni Monaco, et al.
Plos Pathogens|July 15, 2010
Integration preferences of wildtype AAV-2 for consensus rep-binding sites at numerous loci in the human genomeDaniela Hüser, Andreas Gogol-Döring, Timo Lutter, et al.
Nucleic Acids Research|August 19, 2010
Autonomous zinc-finger nuclease pairs for targeted chromosomal deletionCem Söllü, Kaweh Pars, Tatjana I Cornu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2005
Custom zinc-finger nucleases for use in human cellsStephen Alwin, Maja B Gere, Eva Guhl, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 21, 2007
DNA-binding specificity is a major determinant of the activity and toxicity of zinc-finger nucleasesTatjana I Cornu, Stacey Thibodeau-Beganny, Eva Guhl, et al.
Oncoimmunology|June 13, 2022
CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myelomaTobias Bexte, Jamal Alzubi, Lisa Marie Reindl, et al.
Nucleic Acids Research|March 15, 2018
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cellsTafadzwa Mlambo, Sandra Nitsch, Markus Hildenbeutel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 15, 2015
Streptococcus thermophilus CRISPR-Cas9 Systems Enable Specific Editing of the Human GenomeMaximilian Müller, Ciaran M Lee, Giedrius Gasiunas, et al.
Pageof 18

Showing results (81-90 of 172) with videos related to

Sort By:
Pageof 18
Nature Methods|August 26, 2014
Adenoviral vector DNA for accurate genome editing with engineered nucleasesMaarten Holkers, Ignazio Maggio, Sara F D Henriques, et al.
Peerj|December 7, 2020
HIV-1 promoter is gradually silenced when integrated into <i>BACH2</i> in Jurkat T-cellsAnne Inderbitzin, Yik Lim Kok, Lisa Jörimann, et al.
Cancers|June 26, 2020
An Anti-PSMA Immunotoxin Reduces Mcl-1 and Bcl2A1 and Specifically Induces in Combination with the BAD-Like BH3 Mimetic ABT-737 Apoptosis in Prostate Cancer CellsAnie P Masilamani, Viviane Dettmer-Monaco, Gianni Monaco, et al.
Plos Pathogens|July 15, 2010
Integration preferences of wildtype AAV-2 for consensus rep-binding sites at numerous loci in the human genomeDaniela Hüser, Andreas Gogol-Döring, Timo Lutter, et al.
Nucleic Acids Research|August 19, 2010
Autonomous zinc-finger nuclease pairs for targeted chromosomal deletionCem Söllü, Kaweh Pars, Tatjana I Cornu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2005
Custom zinc-finger nucleases for use in human cellsStephen Alwin, Maja B Gere, Eva Guhl, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 21, 2007
DNA-binding specificity is a major determinant of the activity and toxicity of zinc-finger nucleasesTatjana I Cornu, Stacey Thibodeau-Beganny, Eva Guhl, et al.
Oncoimmunology|June 13, 2022
CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myelomaTobias Bexte, Jamal Alzubi, Lisa Marie Reindl, et al.
Nucleic Acids Research|March 15, 2018
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cellsTafadzwa Mlambo, Sandra Nitsch, Markus Hildenbeutel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 15, 2015
Streptococcus thermophilus CRISPR-Cas9 Systems Enable Specific Editing of the Human GenomeMaximilian Müller, Ciaran M Lee, Giedrius Gasiunas, et al.
Pageof 18